Cargando…
Osteogenesis Imperfecta: Current and Prospective Therapies
Osteogenesis Imperfecta (OI) is a group of connective tissue disorders with a broad range of phenotypes characterized primarily by bone fragility. The prevalence of OI ranges from about 1:15,000 to 1:20,000 births. Five types of the disease are commonly distinguished, ranging from a mild (type I) to...
Autores principales: | Botor, Malwina, Fus-Kujawa, Agnieszka, Uroczynska, Marta, Stepien, Karolina L., Galicka, Anna, Gawron, Katarzyna, Sieron, Aleksander L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533546/ https://www.ncbi.nlm.nih.gov/pubmed/34680126 http://dx.doi.org/10.3390/biom11101493 |
Ejemplares similares
-
Searching for new molecular markers for cells obtained from abdominal aortic aneurysm
por: Lesiak, Marta, et al.
Publicado: (2021) -
Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta
por: Fus-Kujawa, Agnieszka, et al.
Publicado: (2023) -
Analysis of miRNAs in Osteogenesis imperfecta Caused by Mutations in COL1A1 and COL1A2: Insights into Molecular Mechanisms and Potential Therapeutic Targets
por: Botor, Malwina, et al.
Publicado: (2023) -
Expression gradient of metalloproteinases and their inhibitors from proximal to distal segments of abdominal aortic aneurysm
por: Augusciak-Duma, Aleksandra, et al.
Publicado: (2021) -
Rosemary Extract-Induced Autophagy and Decrease in Accumulation of Collagen Type I in Osteogenesis Imperfecta Skin Fibroblasts
por: Sutkowska-Skolimowska, Joanna, et al.
Publicado: (2022)